Endovascular Coiling Market Assessment (United States) – Wave 2
A Survey of 51 Neurosurgery and Interventional Neuroradiology Physicians
Deliverable: Survey with key findings.
Study Description:
|
Topic |
Endovascular Coiling Market Assessment |
|
Respondent Type |
Physicians |
|
Specialties Covered |
Neurosurgery and Interventional Neuroradiology |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website Duration: 25 minutes Size: 51 respondents from the United States Fielding Dates: 11th October to 23rd October, 2007 (Wave 2) 22nd June to 16th July, 2007 (Wave 1) |
Objectives:
To understand the current and future trends in the endovascular market, perceptions of various manufacturers and endovascular coils in the
§ Understand the use of microcoil products
§ Compare overall perceptions of various manufacturers (of coiling or coiling related products)
§ Understand attitudes toward Micrus bare platinum coils, Cerecyte microcoil, EV3 Axium, and J&J Orbit
§ Evaluate the familiarity and impact of the Matrix and Platinum Science (MAPS) trial
§ Assess future trends in cerebral aneurysm procedures and future microcoil product usage
Companies and Products Mentioned in This Report:
|
Company |
Ticker Symbol |
Product(s) |
|
Boston Scientific |
BSX |
Matrix2 360 and GDC (Guglielmi) 360 |
|
Micrus Endovascular |
MEND |
Cerecyte Microcoil, Presidio Microcoil, MicruSphere Microcoil, HeliPaq Microcoil, HeliPaq SR Microcoil, InterPaq Microcoil and UltiPaq Microcoil |
|
JNJ / Cordis |
JNJ |
Trufill DCS Orbit |
|
Microvention / Terumo |
MicroPlex Complex (3D) Coils, MicroPlex Helical Coils, MicroPlex HyperSoft Coils, HydroCoils | |
|
EV3 / Micro Therapeutics |
|
Nexus, NXT, Tetris |
Inclusion Criteria and Respondent Demographics
|
Inclusion Criteria
|
§ US-based neurosurgeon or interventional neuroradiologist § Board certified in specialty § In practice between 2 and 30 years § Familiar with minimally invasive procedures for the treatment of cerebral aneurysms § Currently treat patients with cerebral aneurysms using endovascular coiling |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |